Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Industry performance is calculated based on the previous closing price of all industry constituents
Largest Companies in This Industry
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
---|---|---|---|---|---|---|---|
| 374.89 | 45.21% | | | | Buy | |
| 171.37 | 6.60% | | | | Buy | |
| 163.26 | 6.43% | | | | Hold | |
| 228.65 | 6.41% | | | | Buy | |
| 117.25 | 5.30% | | | | Strong Buy | |
| 675.00 | 4.73% | | | | Strong Buy | |
| 164.83 | 3.85% | | | | Strong Buy | |
| 37.78 | 3.08% | | | | Buy | |
| 31.91 | 1.59% | | | | Buy | |
| 97.38 | 1.58% | | | | Hold |
Investing in the Medical Care Facilities Industry
Start Investing in Medical Care Facilities Through These Companies
Top Performing Companies
View MoreName | Last Price | 1Y Target Est. | YTD Return |
---|---|---|---|
| 63.67 | | |
| 37.78 | | |
| 7.38 | | |
| 16.38 | | |
| 5.73 | |
High Growth Companies
View MoreName | Last Price | Growth Estimate | YTD Return |
---|---|---|---|
| | | |
| | | |
| | | |
| | | |
| | |
Medical Care Facilities Research
View MoreDiscover the Latest Analyst and Technical Research for This Industry
EHC: Raising target price to $111.00
ENCOMPASS HEALTH CORP has an Investment Rating of BUY; a target price of $111.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetCHE: Rating increased to a BUY
CHEMED CORP has an Investment Rating of BUY; a target price of $670.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetTHC: Rating increased to a BUY
TENET HEALTHCARE CORP has an Investment Rating of BUY; a target price of $144.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetASTH: Lowering target price to $25.00
ASTRANA HEALTH INC has an Investment Rating of SELL; a target price of $25.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target